DexCom (NASDAQ: DXCM) reported Q1 EPS of $0.32, $0.05 better than the analyst estimate of $0.27. Revenue for the quarter came in at $921 million versus the consensus estimate of $909.93 million.

GUIDANCE:

DexCom sees FY2024 revenue of $4.2-4.35 billion, versus the consensus of $4.327 billion.
Non-GAAP Gross Profit Margin of approximately 63 - 64%
Non-GAAP Operating Margin of approximately 20%
Adjusted EBITDA Margin of approximately 29%

For earnings history and earnings-related data on DexCom (DXCM) click here.